ASD vs. IHE
ASD (Defiance Autism Impact ETF) and IHE (iShares U.S. Pharmaceuticals ETF) are both Health & Biotech Equities funds. A 0.71 correlation means they provide meaningful diversification when combined. ASD charges 0.79%/yr vs 0.42%/yr for IHE.
Performance
ASD vs. IHE - Performance Comparison
Loading charts...
Returns By Period
ASD
- 1D
- 0.51%
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
IHE
- 1D
- -1.12%
- 1M
- 8.27%
- YTD
- 17.45%
- 6M
- 16.42%
- 1Y
- 53.74%
- 3Y*
- 20.36%
- 5Y*
- 11.48%
- 10Y*
- 9.01%
ASD vs. IHE - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
ASD Defiance Autism Impact ETF | 9.64% |
IHE iShares U.S. Pharmaceuticals ETF | 9.99% |
Correlation
The correlation between ASD and IHE is 0.71, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Jun 2, 2026 | 0.71 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ASD vs. IHE — Risk / Return Rank
ASD
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
IHE
ASD vs. IHE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Defiance Autism Impact ETF (ASD) and iShares U.S. Pharmaceuticals ETF (IHE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ASD | IHE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.51 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 6.38 | — |
| Martin ratioReturn relative to average drawdown | — | 19.60 | — |
Loading charts...
Drawdowns
ASD vs. IHE - Drawdown Comparison
The maximum ASD drawdown since its inception was -2.42%, smaller than the maximum IHE drawdown of -38.20%. Use the drawdown chart below to compare losses from any high point for ASD and IHE.
Loading charts...
Drawdown Indicators
| ASD | IHE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -2.42% | -38.20% | +35.78% |
Max Drawdown (1Y)Largest decline over 1 year | — | -8.47% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -15.92% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -16.03% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -29.59% | — |
Current DrawdownCurrent decline from peak | 0.00% | -1.12% | +1.12% |
Average DrawdownAverage peak-to-trough decline | -0.78% | -7.89% | +7.11% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 2.75% | — |
Volatility
ASD vs. IHE - Volatility Comparison
Loading charts...
Volatility by Period
| ASD | IHE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 6.11% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 13.12% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 17.25% | 17.56% | -0.31% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.25% | 16.36% | +0.89% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.25% | 18.01% | -0.76% |
ASD vs. IHE - Expense Ratio Comparison
ASD has a 0.79% expense ratio, which is higher than IHE's 0.42% expense ratio.
Dividends
ASD vs. IHE - Dividend Comparison
ASD's dividend yield for the trailing twelve months is around 0.02%, less than IHE's 1.48% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ASD Defiance Autism Impact ETF | 0.02% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
IHE iShares U.S. Pharmaceuticals ETF | 1.48% | 1.76% | 1.73% | 1.39% | 2.01% | 1.49% | 1.19% | 1.40% | 1.25% | 1.36% | 0.92% | 1.93% |
Frequently Asked Questions
ASD and IHE have a correlation of 0.71, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, IHE is cheaper at 0.42% per year. The better choice depends on whether you care most about return, fees, risk, or income.
IHE is cheaper with a 0.42% expense ratio, compared with 0.79% for ASD.
IHE has the higher dividend yield at 1.48%, compared with 0.02% for ASD.
They also come from different issuers: Defiance and iShares. Their fees differ too: 0.79% for ASD and 0.42% for IHE.
Find the right allocation for ASD and IHE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer